Klinik am See

Research site

Germany Seebad 84, 15562 Rüdersdorf, Germany

1 trial recruiting
Arteriosclerosis · Cardiac failure
Adult patients

About Specializations

Klinik am See in Rüdersdorf, Germany specialises in clinical trials of conditions such as Arteriosclerosis, Cardiac failure, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiology

The medical center is at the forefront of cardiology research, focusing on innovative treatments for heart failure. The institution is dedicated to improving patient outcomes through cutting-edge research and clinical trials.

Heart Failure Management
Advanced Cardiac Therapies
Cardiovascular Biomarkers

By exploring the efficacy of novel therapeutic agents, the center contributes significantly to the understanding and management of heart failure, offering hope for improved quality of life for patients worldwide.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Seebad 8415562 RüdersdorfGermany

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 2

More sites in Rüdersdorf Germany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

4 clinical trials

Arteriosclerosis

Recruiting

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Laroprovstat
Sponsor:AstraZeneca AB

Contact Research Centre

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Pelacarsen
Sponsor:Novartis Pharma AG

Contact Research Centre

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pelacarsen
Sponsor:Novartis Pharma AG

Contact Research Centre

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azilsartan Medoxomil
Sponsor:Novartis Pharma AG

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites